Sin embargo, en los ltimos meses, las autoridades reguladoras de medicamentos tambin han documentado efectos secundarios raros, ocasionalmente graves, asociados con el uso de estos agentes en el tratamiento de la diabetes de los que los mdicos no necesariamente estaban al tanto
Cardiovascular outcome trials that are planned or underway will determine whether such robust cardiometabolic potency through complementary receptor targeting translates into incremental cardiovascular protection, ideally with improved drug tolerability
Studies from the Cleveland Clinic show that mindful eating exercises like this significantly reduce overeating after weight-loss therapy
The safety of commercial GLP-1 patches is unknown since they havent undergone clinical trials or regulatory review
When researchers treated normal-weight mice with the gene therapy and then fed them a high-fat diet, the mice did not gain weight
Alongside these medical benefits, there are some risks of negative effects when taking a regular GLP-1 agonist